1.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000515008, P30CA015083, MC0117, 1260-03, NCI-2009-01199, MAYO-MC0117, NCT00408590
|
2.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000530389, P30CA015083, MC038C, 06-005263, NCI-2009-01194, MAYO-MC038C, MAYO-06-005263, NCT00450814
|